Cannabidiolic acid (CBDA) is the primary compound in raw cannabis, comprising approximately 95% of its total cannabinoids. Non-intoxicating and suitable for therapeutic use, CBDA converts to CBD through decarboxylation when exposed to heat. Research indicates that CBDA may enhance therapeutic effects when combined with CBD, exhibiting 2.7 times greater efficacy. CBDA exhibits anti-inflammatory properties, aids […]
CBDA
This category will feature articles focused on CBDA’s unique properties as the precursor to CBD. Content will delve into CBDA’s potential health benefits, such as its anti-nausea, anti-inflammatory, and anti-cancer effects, as well as how it differs from CBD. You’ll also find articles on how to use raw cannabis to retain CBDA, including recipes and product recommendations, and coverage of the latest research on CBDA’s therapeutic potential.
CBDA: Anti-Inflammatory Potential Explained
CBDA, a non-psychoactive cannabinoid, exhibits significant anti-inflammatory effects through selective inhibition of COX-2 enzymes, making it a promising alternative to traditional NSAIDs for managing inflammation and pain. Its efficacy in relieving inflammation is comparable to traditional NSAIDs, with evidence suggesting it may surpass them in managing chronic pain symptoms. Rodent studies indicate that CBDA is […]
Preserving CBDA in Cannabis Products
Preserving CBDA in cannabis products requires careful consideration of degradation factors, including light exposure, air oxidation, and temperature fluctuations. To minimize degradation, products should be stored in airtight containers in dark environments at room temperature, ideally below 20°C. Cold extraction methods, such as supercritical CO2 extraction, can also help preserve CBDA integrity. Proper packaging, including […]